Mandip S Dhamoon1, Ying-Kuen Cheung2, Janet T DeRosa3, Jose Gutierrez3, Yeseon P Moon2, Ralph L Sacco4,5,6, Mitchell S V Elkind7,3, Clinton B Wright8. 1. Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York. 2. Department of Biostatistics, College of Physicians and Surgeons, Mailman School of Public Health, Columbia University, New York, New York. 3. Department of Neurology, College of Physicians and Surgeons, Mailman School of Public Health, Columbia University, New York, New York. 4. McKnight Brain Institute, Miller School of Medicine, University of Miami, Miami, Florida. 5. Department of Public Health Sciences, Miller School of Medicine, University of Miami, Miami, Florida. 6. Department of Human Genetics, Miller School of Medicine, University of Miami, Miami, Florida. 7. Department of Epidemiology, College of Physicians and Surgeons, Mailman School of Public Health, Columbia University, New York, New York. 8. National Institutes of Health, Bethesda, Maryland.
Abstract
OBJECTIVES: To test associations between subclinical brain infarcts (SBIs) and functional decline independently of intervening clinical vascular events and other vascular risk factors. DESIGN: Longitudinal follow-up for a mean 7.3 years. Generalized estimating equation models were used to test associations between SBIs, number of perivascular spaces (PVSs), baseline Barthel Index (BI), and change in BI, adjusting for sociodemographic, vascular, and cognitive risk factors and for stroke and myocardial infarction occurring during follow-up. SETTING: Population-based prospective cohort study. PARTICIPANTS: Stroke-free individuals from the racially and ethnically diverse Northern Manhattan Study (N=1,290). MEASUREMENTS: Annual functional assessments using the BI (range 0-100). RESULTS: Mean age was 70.6 ± 9.0, 40% of participants were male, 66% were Hispanic, 193 (16%) had SBIs, and 508 (42%) had large PVSs. SBIs were not associated with baseline BI. In a fully adjusted model, there was a change in BI of -0.85 points per year (95% confidence interval (CI)=-1.01 to -0.69); those with SBI had an additional change in BI 0f -0.88 points (95% CI=-1.43 to -0.32). There were no associations between PVS and baseline BI or change in BI. CONCLUSION: In a large population-based study, we found a strong and independent association between "subclinical" markers of cerebrovascular injury and important clinical, person-centered functional trajectories. Future research could clarify the evolution of such subclinical markers over time and test strategies to prevent their progression and minimize related disability. J Am Geriatr Soc 66:2144-2150, 2018.
OBJECTIVES: To test associations between subclinical brain infarcts (SBIs) and functional decline independently of intervening clinical vascular events and other vascular risk factors. DESIGN: Longitudinal follow-up for a mean 7.3 years. Generalized estimating equation models were used to test associations between SBIs, number of perivascular spaces (PVSs), baseline Barthel Index (BI), and change in BI, adjusting for sociodemographic, vascular, and cognitive risk factors and for stroke and myocardial infarction occurring during follow-up. SETTING: Population-based prospective cohort study. PARTICIPANTS: Stroke-free individuals from the racially and ethnically diverse Northern Manhattan Study (N=1,290). MEASUREMENTS: Annual functional assessments using the BI (range 0-100). RESULTS: Mean age was 70.6 ± 9.0, 40% of participants were male, 66% were Hispanic, 193 (16%) had SBIs, and 508 (42%) had large PVSs. SBIs were not associated with baseline BI. In a fully adjusted model, there was a change in BI of -0.85 points per year (95% confidence interval (CI)=-1.01 to -0.69); those with SBI had an additional change in BI 0f -0.88 points (95% CI=-1.43 to -0.32). There were no associations between PVS and baseline BI or change in BI. CONCLUSION: In a large population-based study, we found a strong and independent association between "subclinical" markers of cerebrovascular injury and important clinical, person-centered functional trajectories. Future research could clarify the evolution of such subclinical markers over time and test strategies to prevent their progression and minimize related disability. J Am Geriatr Soc 66:2144-2150, 2018.
Authors: Adam M Brickman; Christiane Reitz; José A Luchsinger; Jennifer J Manly; Nicole Schupf; Jordan Muraskin; Charles DeCarli; Truman R Brown; Richard Mayeux Journal: Arch Neurol Date: 2010-05
Authors: Chuanhui Dong; Nooshin Nabizadeh; Michelle Caunca; Ying Kuen Cheung; Tatjana Rundek; Mitchell S V Elkind; Charles DeCarli; Ralph L Sacco; Yaakov Stern; Clinton B Wright Journal: Neurology Date: 2015-07-08 Impact factor: 9.910
Authors: Ming Yao; Dominique Hervé; Eric Jouvent; Marco Duering; Sonia Reyes; Ophelia Godin; Jean Pierre Guichard; Martin Dichgans; Hugues Chabriat Journal: Cerebrovasc Dis Date: 2014-02-05 Impact factor: 2.762
Authors: D Shinar; C R Gross; K S Bronstein; E E Licata-Gehr; D T Eden; A R Cabrera; I G Fishman; A A Roth; J A Barwick; S C Kunitz Journal: Arch Phys Med Rehabil Date: 1987-10 Impact factor: 3.966
Authors: E M Gentry; W D Kalsbeek; G C Hogelin; J T Jones; K L Gaines; M R Forman; J S Marks; F L Trowbridge Journal: Am J Prev Med Date: 1985 Nov-Dec Impact factor: 5.043
Authors: Tatjana Rundek; Magdalena Tolea; Taylor Ariko; Eric A Fagerli; Christian J Camargo Journal: Neurotherapeutics Date: 2021-12-22 Impact factor: 6.088